Documents filed

Documents filed with Borsa Italiana available in pdf format
2024  Explanatory Memorandum on Authorisation to purchase and use trasury shares  - ( file pdf - 390 kb) 26/03/2024
2024  Report on the remuneration policy and the remuneration paid  - ( file pdf - 630 kb) 26/03/2024
2024  ANNUAL FINANCIAL STATEMENTS 2023  - ( file pdf - 3 mb) 25/03/2024
2024  COMPANY PRESENTATION_EURONEXT STAR CONFERENCE 2024  - ( file pdf - 3 mb) 18/03/2024
2024  Proxy form ex 135 undecies  - ( file pdf - 239 kb) 15/03/2024
2024  Proxy form ex 135 novies  - ( file pdf - 213 kb) 15/03/2024
2024  Explanatory memorandum on the increase in compensation for the Board of Statutory Auditors  - ( file pdf - 346 kb) 15/03/2024
2024  Explanatory memorandum to amend total fixed annual remuneration of the BoD  - ( file pdf - 363 kb) 15/03/2024
2024  Explanatory memorandum on remuneration policy and remuneration paid  - ( file pdf - 370 kb) 15/03/2024
2024  NOTICE CALLING THE ORDINARY GENERAL MEETING OF SHAREHOLDERS  - ( file pdf - 390 kb) 15/03/2024
2024  PHN_Company Visit 22 Feb 2024  - ( file pdf - 3 mb) 22/02/2024
2024  PHN_FRANKFURT MIDCAP CONFERENCE 2024  - ( file pdf - 2 mb) 07/02/2024
2023  INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023  - ( file pdf - 1 mb) 10/11/2023
2023  INTERIM MANAGEMENT REPORT AS AT 30 JUNE 2023  - ( file pdf - 2 mb) 19/09/2023
2023  Pharmanutra - Report on Corporate Governance and Ownership structure_2022  - ( file pdf - 771 kb) 31/03/2023
2023  Pharmanutra - Annual Financial report  - ( file pdf - 4 mb) 31/03/2023
2023  Explanatory Memorandum on Remuneration Policy  - ( file pdf - 390 kb) 27/03/2023
2023  Explanatory Memorandum on Financial Statements  - ( file pdf - 395 kb) 27/03/2023
2022  INTERIM FINANCIAL REPORT AS AT 30 SEPTEMBER 2022  - ( file pdf - 1 mb) 14/11/2022
2022  PHARMANUTRA - H1 Financial Report as of 30 June 2022  - ( file pdf - 13 mb) 14/09/2022
 

Bilanci, Semestrali, Trimestrali, Statuti Pharmanutra


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.